IgA nephropathy
IgA nephropathy (IgAN) is a leading cause of CKD and renal failure. Recent international
collaborative efforts have led to important discoveries that have improved our understanding …
collaborative efforts have led to important discoveries that have improved our understanding …
Current treatment of IgA nephropathy
IgA nephropathy (IgAN) is the most common type of glomerulonephritis in Asia and the
Western world. In most patients, it follows an asymptomatic to oligosymptomatic course and …
Western world. In most patients, it follows an asymptomatic to oligosymptomatic course and …
Effectiveness of mycophenolate mofetil among patients with progressive IgA nephropathy: a randomized clinical trial
Importance The role of mycophenolate mofetil (MMF) in management of immunoglobulin A
nephropathy (IgAN) remains highly controversial. Objective To evaluate the efficacy and …
nephropathy (IgAN) remains highly controversial. Objective To evaluate the efficacy and …
IgA nephropathy
Abstract Globally, IgA nephropathy (IgAN) is the most common primary glomerulonephritis
that can progress to renal failure. The exact pathogenesis of IgAN is not well defined, but …
that can progress to renal failure. The exact pathogenesis of IgAN is not well defined, but …
IgA nephropathy in adults—treatment standard
PJ Gleeson, MM O'Shaughnessy… - Nephrology Dialysis …, 2023 - academic.oup.com
Immunoglobulin A nephropathy (IgAN) is the most common primary form of glomerular
disease worldwide and carries a high lifetime risk of kidney failure. The underlying …
disease worldwide and carries a high lifetime risk of kidney failure. The underlying …
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis
Glomerulonephritis (GN) is an important cause of morbidity and mortality in patients of all
ages throughout the world. Because these disorders are relatively rare, it is difficult to …
ages throughout the world. Because these disorders are relatively rare, it is difficult to …
IgA nephropathy: current understanding and perspectives on pathogenesis and targeted treatment
Y Du, T Cheng, C Liu, T Zhu, C Guo, S Li, X Rao, J Li - Diagnostics, 2023 - mdpi.com
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide, with varied clinical and histopathological features between individuals …
worldwide, with varied clinical and histopathological features between individuals …
Mycophenolate mofetil combined with prednisone versus full-dose prednisone in IgA nephropathy with active proliferative lesions: a randomized controlled trial
JH Hou, WB Le, N Chen, WM Wang, ZS Liu… - American Journal of …, 2017 - Elsevier
Background Observational studies suggest that patients with immunoglobulin A
nephropathy (IgAN) with active proliferative lesions show a good response to …
nephropathy (IgAN) with active proliferative lesions show a good response to …
Is IgA nephropathy the same disease in different parts of the world?
H Zhang, J Barratt - Seminars in Immunopathology, 2021 - Springer
Since it was first described in 1968, immunoglobulin A nephropathy (IgAN) is understood to
be the most common form of glomerulonephritis worldwide. The diagnosis of IgAN depends …
be the most common form of glomerulonephritis worldwide. The diagnosis of IgAN depends …
Is immunoglobulin A nephropathy different in different ethnic populations?
Immunoglobulin A nephropathy (IgAN) is one of the commonest global patterns of primary
glomerulonephritis and remains a leading cause of chronic kidney disease and end‐stage …
glomerulonephritis and remains a leading cause of chronic kidney disease and end‐stage …